These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31787414

  • 1. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
    Jiang M, Li P, Wang W, Zhao M, Atif N, Zhu S, Fang Y.
    Vaccine; 2020 Jan 29; 38(5):1057-1064. PubMed ID: 31787414
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
    You JH, Ming WK, Chan PK.
    Hum Vaccin Immunother; 2015 Jan 29; 11(3):564-71. PubMed ID: 25714506
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT.
    BMC Infect Dis; 2015 Oct 27; 15():465. PubMed ID: 26503131
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.
    García A, Ortiz de Lejarazu R, Reina J, Callejo D, Cuervo J, Morano Larragueta R.
    Hum Vaccin Immunother; 2016 Sep 27; 12(9):2269-77. PubMed ID: 27184622
    [Abstract] [Full Text] [Related]

  • 10. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.
    Zeevat F, Crépey P, Dolk FCK, Postma AJ, Breeveld-Dwarkasing VNA, Postma MJ.
    Value Health; 2021 Jan 27; 24(1):3-10. PubMed ID: 33431150
    [Abstract] [Full Text] [Related]

  • 11. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK, Song JY, Jang H, Kim TH, Koo H, Varghese L, Han E.
    Pharmacoeconomics; 2018 Dec 27; 36(12):1475-1490. PubMed ID: 30251078
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population.
    Capri S, Barbieri M, de Waure C, Boccalini S, Panatto D.
    Hum Vaccin Immunother; 2018 Jun 03; 14(6):1331-1341. PubMed ID: 29425079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly.
    Mullikin M, Tan L, Jansen JP, Van Ranst M, Farkas N, Petri E.
    Infect Dis Ther; 2015 Dec 03; 4(4):459-87. PubMed ID: 26350238
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    Yun JW, Choi MJ, Shin GS, Lim JO, Noh JY, Kim YK, Song JY, Kim WJ, Choi SE, Cheong HJ.
    PLoS One; 2019 Dec 03; 14(1):e0209643. PubMed ID: 30682030
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis.
    Zhu D, Lv M, Bai Y, Wu J, He P.
    Vaccine; 2022 Feb 11; 40(7):994-1000. PubMed ID: 35065820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.